Skip to content

comparison of effectiveness of two interventions in improvement of pain and function in adhesive capsulitis

Effectiveness of ultrasound guided intraarticular injection of platelet rich plasma compared with triamcinolone hexacetonide in improvement of pain and function in patients with adhesive capsulitis: A randomized controlled trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054516
Enrollment
64
Registered
2023-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Intra-articular injection of Platelet rich plasma into the shoulder: Single injection of 4ml Platelet rich plasma into the shoulder joint under ultrasound guidance Control Intervention1

Sponsors

Yendrembam Anamika Chanu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of adhesive capsulitis, Patients who are willing to comply with the study and follow up assessments

Exclusion criteria

Exclusion criteria: Patients with uncontrolled diabetes History of shoulder trauma/surgery History of injection in the shoulder joint in past three months Non-steroidal anti-inflammatory drugs intake in last seven days Coagulopathy Thrombocytopenia (1.5 lakh/microlitre) Autoimmune disorders Impaired cognition Any febrile or infectious disease (systemic & local)

Design outcomes

Primary

MeasureTime frame
Shoulder Pain and Function in terms of Shoulder Pain and Disability Index (SPADI)Timepoint: 1 week, 4 week, 12 week, 24 week

Secondary

MeasureTime frame
Pain in terms of Visual Analogue Scale (VAS)Timepoint: 1 week, 4 weeks, 12 weeks, 24 weeks;Shoulder function in terms of Range of MotionTimepoint: 1 week, 4 weeks, 12 weeks, 24 weeks

Countries

India

Contacts

Public ContactDr Naorem Bimol

Regional Institute of Medical Sciences

bimoldr@yahoo.com7005291542

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026